Xeris Biopharma Holdings Inc (FRA:2B30) Stock News, Headlines & Updates
Xeris Biopharma Holdings Inc Stock News from GuruFocus
- 1
Jul 03, 2024
Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Business Wire • 1:00pm
Jun 03, 2024
Xeris Presents New Post Hoc Analysis on Effects of Levoketoconazole (Recorlev®) in Cushing's Syndrome Patients at ENDO 2024
Business Wire • 7:00am
May 30, 2024
Xeris to Participate in the Jefferies Global Healthcare Conference
Business Wire • 7:00am
May 10, 2024
Xeris Biopharma Holdings Inc (XERS) Q1 2024 Earnings: Revenue Growth Amidst Challenges
GuruFocus Research • 1:21pm
May 06, 2024
Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement with Beta Bionics
Business Wire • 7:00am
May 02, 2024
Xeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024
Business Wire • 7:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news